“showed a trend”

A study conducted by the US Lymphoma CAR-T Consortium showed that patients who received bridging therapy showed a trend toward inferior PFS compared to non-bridged patients (p = 0.06).

FAZ area was significantly larger in the T+M group than in controls ( P = 0.01) and showed a trend toward enlargement compared to the T group ( P = 0.06).

In the Baby Animals task, generalization accuracy was significantly associated with age, β = 0.01, SE = 0.001, t (180.6) = 8.90, p < 0.001, 95% CI [0.008, 0.012], and showed a trend toward a significant association with verbal intelligence, β = 0.003, SE = 0.002, t (180.0) = 1.90, p = 0.060, 95% CI [−0.0001, 0.007].

5 E); the main effect of rearing condition showed a trend toward increased DA across all barren reared groups F(1,129) = 3.59, p ≤ 0.06).

5.45 months, p = 0.225), while patients who required dose reductions due to adverse events showed a trend toward longer OS compared with those without dose reduction (5.45 vs. 2.92 months, p = 0.060), although not statistically significant.

Bacterial flow cytometry analysis of AMD fecal samples ( Fig 4 A) showed a trend toward increased IgA-coated bacteria with higher AMD GRS ( P = 0.06; Spearman’s r = 0.2) ( Fig 4 B).

Furthermore, F1 HFD showed a trend in decreased plasma testosterone ( Figure 3 e, p = 0.06).

Furthermore a MANOVA of the Procrustes coordinates showed a trend towards sex differences in centroid size (F 1, 107 = 3.68, P = 0.06), with slightly larger male centroids, and in the size-corrected shape space (F 22, 2354 = 1.14, P = 0.08).

In the ciliary body, CD45 + expression showed a trend toward elevation in EAU mice (0.442% ± 0.910% vs. 0.088% ± 0.023%, p = 0.0600) compared to controls, but this was not statistically significant (Figure 2D ). 3.3 Expression of IL ‐ 17A significantly increased in the retina and ciliary body of EAU mice The expression of IL‐17A, a marker for the activation of the T‐cell subset, Th17, was assessed in the retina, ciliary body, and cornea in EAU and control mice.

Muscle weight of larger muscle groups, such as the gastrocnemius-soleus complex and the quadriceps muscle were not statistically significantly different between groups, although the quadriceps showed a trend toward lower muscle weight in diseased mice (−14.3%, p = 0.06) ( Figure 3c ).

• However, the Digit Span Forward test showed a trend toward poorer performance in the moderate‐to‐severe WMH group ( p =0.06), suggesting possible frontal lobe vulnerability. • Depression and neuropsychiatric symptoms did not differ significantly between groups.

Post hoc comparisons for the main effect of treatment showed a trend for a reduction in GluN2B in CAST + testosterone compared to CAST mice ( p = 0.06) ( Figure 3(e) ).

Similar trends were found for the CNR values—the iliac station showed a trend of lower values compared to tibial ( p = 0.06), while the iliac vs. femoral ( p = 0.28) or femoral vs. tibial ( p = 1.00) stations did not show significant differences.

The FOXO3 expression data set showed a trend towards enrichment for changes in expression of genes with PRDM1 binding sites ( p = 0.06).

However, Firmicutes showed a trend toward a significant fluctuation ( p = 0.06, Kruskal-Wallis test).

Patients who underwent BrM-directed therapy showed a trend toward longer survival from BrM diagnosis when compared with patients receiving supportive care only (median OS, 6.5 vs 0.8 months, P = . 060).

However, the univariate survival analyses confirmed that the patients with high drebrin + T cell infiltration showed a trend toward a short RFS (hazard ratio (HR), 2.40; p = 0.06; 95% confidence interval (CI), 0.95–6.02) ( Figure 3 A).

The A allele of rs1447295 was significantly associated with the risk of sporadic prostate cancer ( p = 0.04; age-adjusted OR, 1.34), while the G allele of rs6983267 showed a trend towards being a high-risk allele ( p = 0.06; age-adjusted OR, 1.27).

Complete case analysis showed a trend for higher urine sEPCR levels at the time of biopsy when severe microcirculatory inflammation was present (p = 0.06) ( figure 6 ).

Both archaeal and bacterial communities in rumen liquids and solids showed decreased dispersion from 8 weeks to 1 year to 2 years (PERMDISP, P < 0.05), except archaeal dispersion in rumen solids which only showed a trend (PERMDISP P = 0.06, Supplementary Table 5 ).

Patients in whom an increase in these metabolites was observed showed a trend towards better survival using the 2-years composite endpoint (HR 2.46, p = 0.06).

Notably, PMS supplementation led to a significant reduction in serum COR levels ( p < 0.05) and showed a trend towards decreasing serum NE levels ( p = 0.06). 3.3.

Regarding risk factors of the occurrence of ≥G3 GI toxicity, univariate analysis in all patients showed that a history of abdominopelvic surgery was a significant risk factor ( P = 0.01), and the use of VEGF-targeted agents showed a trend of high incidence ( P = 0.06).

A generalized linear mixed‐effects model on children's PA scores with group as the fixed‐effect factor showed a trend towards an effect of group ( β = .833, SE = 0.444, t = 1.878, p = .060), indicating that the FR children tended to perform more poorly on this task than the No‐FR children.

After training, both groups showed a trend of improvements in the lower extremity-Brunnstrom stage ( p = 0.06 and 0.08, respectively).